Surgical resection for hepatocellular carcinoma: Moving from what can be done to what is worth doing-Reference-Cited by-同舟云学术

Surgical resection for hepatocellular carcinoma: Moving from what can be done to what is worth doing

Published:2015-05-29 Issue:2 Volume:62 Page:340-342
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Romagnoli Renato¹,Mazzaferro Vincenzo²,Bruix Jordi³⁴

Affiliation:

1. General Surgery 2U and Liver Transplantation Center AOU Città della Salute e della Scienza di Torino; University of Turin; Turin Italy

2. Gastrointestinal Surgery and Liver Transplantation; Istituto Nazionale Tumori IRCCS; Milan Italy

3. Barcelona Clinic Liver Cancer Group Liver Unit, Hospital Clínic; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) University of Barcelona; Barcelona Spain

4. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas; University of Barcelona; Barcelona Spain

Funder

CIBERehd

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.27831/fullpdf

Reference9 articles.

1. American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update;Bruix;Hepatology,2011

2. European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma;European Association for the Study of the Liver;J Hepatol,2012

3. Portal hypertension: contraindication to liver surgery?;Capussotti;World J Surg,2006

4. Is portal hypertension a contraindication to hepatic resection?;Cucchetti;Ann Surg,2009

5. The role of hepatic resection in the treatment of hepatocellular cancer;Roayaie;Hepatology,2015

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of tryptophan metabolism patterns to predict prognosis and immunotherapeutic responses in hepatocellular carcinoma;Aging;2023-08-03

2. Holistic management of hepatocellular carcinoma: The hepatologist's comprehensive playbook;Liver International;2022-10-11

3. Histogram peritumoral enhanced features on MRI arterial phase with extracellular contrast agent can improve prediction of microvascular invasion of hepatocellular carcinoma;Quantitative Imaging in Medicine and Surgery;2022-02

4. Treatments of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Current Status and Controversy;Journal of Clinical and Translational Hepatology;2021-08-10

5. Radiolabeled Peptide Probes for Liver Cancer Imaging;Current Medicinal Chemistry;2020-12-08